Iroko Pharmaceuticals, LLC Company Profile

17:36 EDT 25th May 2015 | BioPortfolio

Iroko is a pharmaceutical company focused on specialty therapeutic areas. The company acquires, develops and maximizes the potential of currently marketed products on a global basis through focused selling and marketing efforts and product-life-cycle management activities including development of new formulations to improve patient treatment.


News Articles [11 Associated News Articles listed on BioPortfolio]

Iroko Pharmaceuticals gets new patent for Zorvolex from USPTO

Iroko Pharmaceuticals has announced the receipt of a patent for the composition of matter covering Zorvolex (diclofenac) capsules 18 mg or 35 mg.

Iroko launches Zorvolex in Lebanon for acute and chronic pain

Iroko Pharmaceuticals has launched Zorvolex (diclofenac) capsules, a nonsteroidal anti-inflammatory drug (NSAID), in 18mg and 35mg dosage strengths by prescription in Lebanon.

FDA accepts to review Iroko NDA for SoluMatrix Meloxicam in osteoarthritis pain

The US Food and Drug Administration (FDA) has accepted for review Iroko Pharmaceuticals' new drug application (NDA) for SoluMatrix meloxicam, a low dose nonsteroidal anti-inflammatory drug (NSAID), fo...

Iroko Pharmaceuticals Appoints New Member to Company’s Board of Directors

Industry veteran brings more than 30 years of experience to support Company’s growing low dose NSAID franchise Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical ...

Iroko Pharmaceuticals Announces Acceptance of U.S. Filing for SoluMatrix® Meloxicam in Osteoarthritis Pain

FDA Approval Sought for Iroko’s Third SoluMatrix® NSAID Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of a...

FDA agrees to review Iroko's NDA for osteoarthritis pain drug

The FDA will review Iroko Pharmaceuticals' new drug application for SoluMatrix meloxicam, a low-dose nonsteroidal anti-inflam -More- 

Iroko Pharmaceuticals Granted New Patent for ZORVOLEX®

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today announced the receipt of a patent for the composition ...

Iroko Pharmaceuticals Announces First International Launch of ZORVOLEX®

Iroko’s First Low Dose NSAID Now Available for Acute and Chronic Pain Outside of the U.S. Iroko Pharmaceuticals Inc., a global specialty pharmaceutical company dedica...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [5 Associated Companies listed on BioPortfolio]

Iroko Pharmaceuticals, LLC

Iroko is a pharmaceutical company focused on specialty therapeutic areas. The company acquires, develops and maximizes the potential of currently marketed products on a global bas...

Iroko Pharmaceuticals, LLC and SynopiaRx LLC

Iroko is a pharmaceutical company focused on the development and commercialization of innovative specialty therapeutic products. The company acquires, develops and maximizes the p...

Iroko Cardio International Sàrl

IROKO Cardio has been founded to organize and support the commercial effort for Aggrastat. In close cooperation with our worldwide distribution partners, we aim to provide state o...

Iroko Pharmaceuticals Inc.

Iroko Pharmaceuticals, LLC and Aptuit Inc.

More Information about "Iroko Pharmaceuticals, LLC" on BioPortfolio

We have published hundreds of Iroko Pharmaceuticals, LLC news stories on BioPortfolio along with dozens of Iroko Pharmaceuticals, LLC Clinical Trials and PubMed Articles about Iroko Pharmaceuticals, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Iroko Pharmaceuticals, LLC Companies in our database. You can also find out about relevant Iroko Pharmaceuticals, LLC Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record